F16L (p.Phe16Leu) variant of VDR (Vitamin D3 receptor)

F16L (p.Phe16Leu) in VDR (Vitamin D3 receptor) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.

F16L (p.Phe16Leu) variant details